Literature DB >> 29246667

Serum 25-hydroxyvitamin D, bone turnover markers and bone mineral density in postmenopausal women with hip fractures.

Jixing Fan1, Ning Li1, Xiaofeng Gong1, Liang He2.   

Abstract

BACKGROUND: Vitamin D and bone turnover markers (BTMs) might have an effect on the occurrence of acute hip fracture, while the current results are conflicting. The purpose of this study is to explore the relationship between serum 25(OH)D, bone turnover markers and bone mineral density in Chinese postmenopausal women with hip fracture.
METHODS: A total of 277 patients with hip fractures and 272 patients without fractures were included in this study. The serum 25(OH)D, bone formation markers, including N-terminal extension propeptide of type-I collagen (P1NP), alkaline phosphatase (ALP) and osteocalcin(OC), bone resorption markers, including C-terminal telopeptide of type-I collagen (CTX-1), and bone mineral density were collected and analyzed.
RESULTS: Women with hip fractures had significantly lower concentrations of serum 25(OH)D, higher concentrations of serum CTX-1, P1NP and OC, lower concentrations of femoral neck and total hip bone mineral density (P<0.05). After adjustment for age and other confounding factors, multiple logistic regression analysis showed that serum 25(OH)D (OR=0.878, 95%CI=0.855-0.902, P<0.001), CTX-1 (OR=4.884, 95%CI=2.419-9.861, P<0.001)and total hip BMD (OR=0.141, 95%CI=0.034-0.577, P=0.006) were independent risk factors for hip fractures in postmenopausal women. The receiver operating characteristics curves showed that serum 25(OH)D had a good AUC value (0.830).
CONCLUSIONS: In this study, lower concentrations of serum 25(OH)D and total hip bone mineral density were widely existed in Chinese postmenopausal women with hip fractures. Furthermore, bone resorption was more active than bone formation in senile postmenopausal women. Therefore, monitoring the alteration of serum CTX-1 in clinically might be useful for fracture prevention.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29246667     DOI: 10.1016/j.cca.2017.12.015

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.

Authors:  Carolyn J Crandall; Sowmya Vasan; Andrea LaCroix; Meryl S LeBoff; Jane A Cauley; John A Robbins; Rebecca D Jackson; Douglas C Bauer
Journal:  J Bone Miner Res       Date:  2018-06-19       Impact factor: 6.741

2.  Association of serum 25-hydroxyvitamin D (25(OH)D) levels with the gut microbiota and metabolites in postmenopausal women in China.

Authors:  Jinhua Gong; Lina He; Qinyuan Zou; Yangyang Zhao; Bangzhou Zhang; Rongmu Xia; Baolong Chen; Man Cao; Wenxiu Gong; Lin Lin; Xiujuan Lin; Guowei Wang; Muyun Guo; Jianquan He; Chuanxing Xiao; Jian Chen
Journal:  Microb Cell Fact       Date:  2022-07-11       Impact factor: 6.352

3.  [Value of serum alkaline phosphatase for predicting 2-year fracture in patients with chronic kidney disease on dialysis].

Authors:  Jianyi Pan; Haitang Hu; Wei Zhang; Jinzhong Chen; Xianrui Dou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30

4.  Analysis of Combined Indicators for Risk of Osteoporotic Hip Fracture in Elderly Women.

Authors:  Jin-Hui Zhao; Hui-Peng Shi; Da-Jun Jiang; Ling-Tian Wang; Sheng-Bao Chen; Wei-Tao Jia
Journal:  Orthop Surg       Date:  2021-05-04       Impact factor: 2.071

5.  Circulating MicroRNA Expression, Vitamin D, and Hypercortisolism as Predictors of Osteoporosis in Elderly Postmenopausal Women.

Authors:  Hadeel A Al-Rawaf; Ahmad H Alghadir; Sami A Gabr
Journal:  Dis Markers       Date:  2021-12-13       Impact factor: 3.434

6.  The Associations of Serum Vitamin D and Bone Turnover Markers with the Type and Severity of Hip Fractures in Older Women.

Authors:  Jinhui Zhao; Qianying Cai; Dajun Jiang; Lingtian Wang; Shengbao Chen; Weitao Jia
Journal:  Clin Interv Aging       Date:  2020-10-15       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.